back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-02 16:10 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+100,000 vol |
100,000 | |
| Filed 2025-10-02 16:08 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-05 15:10 Tx date 2025-09-05 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-6,667 vol |
0 | |
| Filed 2025-09-05 15:09 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-10,192 vol |
1,132 | |
| Filed 2025-09-05 15:07 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-36,000 vol |
4,000 | |
| Filed 2025-01-30 15:52 Tx date 2025-01-27 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-158,532 vol |
11,324 | |
| Filed 2025-01-30 15:49 Tx date 2020-01-02 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-19,777,670 vol |
119,856 | |
| Filed 2025-01-30 15:21 Tx date 2025-01-27 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-93,333 vol |
6,667 | |
| Filed 2025-01-30 15:17 Tx date 2025-01-27 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-560,000 vol |
40,000 | |
| Filed 2025-01-30 14:27 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,324 | ||
| Filed 2020-01-06 18:53 Tx date 2020-01-02 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-35,836,846 vol |
||
| Filed 2019-02-09 16:57 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-20 14:24 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,206,000
+200,000 vol $6.03 each |
600,000 | |
| Filed 2022-12-28 15:45 Tx date 2022-12-28 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$128,357
+28,000 vol $4.58 each |
169,856 | |
| Filed 2022-12-20 16:12 Tx date 2022-12-20 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$117,713
+22,000 vol $5.35 each |
141,856 | |
| Filed 2022-07-10 12:45 Tx date 2022-07-10 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,667 vol |
400,000 | |
| Filed 2022-06-29 11:53 Tx date 2022-06-29 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-3,333 vol |
100,000 | |
| Filed 2022-01-14 11:57 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
406,667 | |
| Filed 2021-08-12 16:03 Tx date 2021-08-12 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+70,000 vol |
103,333 | |
| Filed 2021-07-08 14:31 Tx date 2021-07-08 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+30,000 vol |
33,333 |